Inovalon, a provider of data-driven healthcare solutions, announced on February 12, 2026, an expanded collaboration with Oracle to enhance its ScriptMed® specialty and infusion pharmacy management software. The initiative aims to standardize the software on the Oracle Autonomous AI Database within the Oracle Cloud Infrastructure (OCI). As part of this collaboration, Oracle has recognized Inovalon as a Global Leaders Champion for its innovative use of Oracle’s technology to scale ScriptMed for transaction processing.
Çetin Özbütün, executive vice president of Autonomous AI Database Technologies at Oracle, stated that the Global Leaders Champions program identifies companies that demonstrate leadership in their sector while successfully implementing Oracle data management solutions. “A company like Inovalon, with a demonstrated ability to operate at significant scale while continuing to innovate, is a natural choice for our 2025 Global Leaders Champion recognition,” he added.
The specialty pharmacy and infusion sectors are currently experiencing rapid growth, driven by a robust pipeline of complex therapies that also impose stringent regulatory and data management requirements. Traditional pharmacies, which often rely on expensive on-premises infrastructure and manual database management, face challenges in meeting increasing transaction volumes and scalability demands.
The expanded collaboration between Inovalon and Oracle is designed to equip pharmacies with a flexible, robust, and scalable technology solution. This technology will enable pharmacies to move away from infrastructure management toward business growth, allowing them to introduce new therapies, expand their geographical reach, and manage higher patient volumes with confidence.
Ernie Shopes, President of Inovalon’s Pharmacy Business Unit, emphasized the strategic importance of this collaboration. “Our expanded engagement with Oracle is more than infrastructure. It’s a strategic foundation for pharmacies to thrive in this era of growth, reflecting how pharmacy operations are evolving to remove barriers in favor of prioritizing patient-centric care amid rising therapy complexity and volume,” he noted.
ScriptMed is a comprehensive, data-enabled solution that assists specialty and infusion pharmacy operations in reducing time-to-fill, lowering costs, enhancing patient experience, and improving outcomes. The software is designed to handle various pharmacy functions, including prescription intake, dispensing workflows, fulfillment, inventory management, clinical management, revenue cycle management, and day-to-day transaction processing, all within secure and compliant environments.
Inovalon is recognized for its capabilities in data-driven healthcare, particularly through its Inovalon ONE® Platform, which integrates national-scale connectivity, real-time primary source data access, and advanced analytics. The platform serves over 50,000 active, licensed customers, drawing insights from more than 97 billion medical events involving 1.1 million physicians and impacting 454 million unique lives. For further details, visit Inovalon’s official website.
This enhanced partnership between Inovalon and Oracle reflects a broader trend in the healthcare sector, where technology plays a crucial role in managing increasingly complex therapies and patient care demands. As the landscape continues to evolve, the ability to leverage data effectively will be imperative for healthcare providers aiming to maintain competitiveness and ensure high-quality patient outcomes.
See also
Pershing Square Invests $2 Billion in Meta’s AI Strategy Amid Shift from Metaverse
Global AI Titans Join India AI Impact Summit 2026 to Forge Strategic Partnerships
Germany”s National Team Prepares for World Cup Qualifiers with Disco Atmosphere
95% of AI Projects Fail in Companies According to MIT
AI in Food & Beverages Market to Surge from $11.08B to $263.80B by 2032
